Pharvaris is a biotechnology company in the healthcare sector on NASDAQ, led by Berndt Modig, with a market cap of $1.6B. As of Q3 2025, 90% of shares are held by 83 institutional investors, with GENERAL ATLANTIC LLC as the largest holder at 12.49%.
Overview of institutional ownership in PHVS as of Q3 2025 with a market cap of $1.6B
Based on market cap of $1.6B as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in PHVS as of Q3 2025
| Institution | Position Value |
|---|---|
G GENERAL ATLANTIC LLC Institution | $200.4M 6.02% of portfolio |
FMR LLC Institution | $159.7M 0.01% of portfolio |
Foresite Capital Management IV, LLC Venture Capital | $119.2M 65.29% of portfolio |
V venBio Partners LLC Institution | $115.8M 65.62% of portfolio |
VIKING GLOBAL INVESTORS LP Hedge Fund•Long/Short | $91.2M 0.24% of portfolio |
E EQT Fund Management S.a r.l. Institution | $85.4M 4.59% of portfolio |
B Bain Capital Life Sciences Investors, LLC Institution | $79.4M 5.27% of portfolio |
DEERFIELD MANAGEMENT CO /NY Hedge Fund•Long/Short | $60.9M 1.01% of portfolio |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | $60.3M 2.95% of portfolio |
Paradigm Biocapital Advisors LP Hedge Fund•Long/Short | $45.8M 1.36% of portfolio |
Institutional buying and selling activity for PHVS in Q3 2025
| Institution | Net Bought |
|---|---|
E EQT Fund Management S.a r.l. Institution | +$85.4M +3.4M shares |
WELLINGTON MANAGEMENT CO LLP Long Only Manager | +$43.3M +1.7M shares |
FMR LLC Institution | +$24.4M +976.8K shares |
S Saturn V Capital Management LLC Hedge Fund•Sector | +$22.1M +886.3K shares |
Paradigm Biocapital Advisors LP Hedge Fund•Long/Short | +$19.3M +772.6K shares |
K Kynam Capital Management, LP Hedge Fund•Long/Short | +$16.8M +675.0K shares |
BALYASNY ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy | +$15.6M +625.8K shares |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | +$12.7M +507.0K shares |
G GENERAL ATLANTIC LLC Institution | +$12.5M +500.0K shares |
Point72 Asset Management, L.P. Hedge Fund•Multi-Strategy | +$12.0M +481.8K shares |
| Institution | Net Sold |
|---|---|
VR Adviser, LLC Venture Capital | −$34.3M −1.4M shares |
S SPHERA FUNDS MANAGEMENT LTD. Institution | −$4.8M −190.5K shares |
R Rosalind Advisors, Inc. Institution | −$3.9M −223.6K shares |
B Bain Capital Life Sciences Investors, LLC Institution | −$3.0M −122.1K shares |
C Cormorant Asset Management, LLC Hedge Fund•Long/Short | −$2.3M −91.5K shares |
Soleus Capital Management, L.P. Hedge Fund•Long/Short | −$2.1M −85.9K shares |
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC Long Only Manager | −$974.6K −55.4K shares |
A ALPS ADVISORS INC ETF Provider | −$517.4K −29.4K shares |
NORTHERN TRUST CORP Institution | −$432.0K −17.3K shares |
HighVista Strategies LLC Fund of Funds | −$417.8K −23.7K shares |
Institutions that initiated new positions or completely exited PHVS in Q3 2025
| Institution | Position Value |
|---|---|
E EQT Fund Management S.a r.l. Institution | $85.4M 3.4M shares |
WELLINGTON MANAGEMENT CO LLP Long Only Manager | $43.3M 1.7M shares |
S Saturn V Capital Management LLC Hedge Fund•Sector | $22.1M 886.3K shares |
K Kynam Capital Management, LP Hedge Fund•Long/Short | $16.8M 675.0K shares |
BALYASNY ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy | $15.6M 625.8K shares |
B BAKER BROS. ADVISORS LP Hedge Fund•Sector | $9.4M 375.0K shares |
Polar Capital Holdings Plc Long Only Manager | $6.6M 264.7K shares |
Ikarian Capital, LLC Hedge Fund•Event Driven | $5.2M 210.2K shares |
Integral Health Asset Management, LLC Hedge Fund•Sector | $5.0M 200.0K shares |
G GREAT POINT PARTNERS LLC Private Equity | $3.9M 155.1K shares |
| Institution | Previous Position |
|---|---|
R Rosalind Advisors, Inc. Institution | $3.9M 223.6K shares |
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC Long Only Manager | $974.6K 55.4K shares |
A ALPS ADVISORS INC ETF Provider | $517.4K 29.4K shares |
HighVista Strategies LLC Fund of Funds | $417.8K 23.7K shares |
BARCLAYS PLC Institution | $49.2K 2.8K shares |
WELLS FARGO & COMPANY/MN Institution | $17.6K 1.0K shares |
Institutions with the largest Call and Put options positions in PHVS as of Q3 2025
| Institution | Position Value |
|---|---|
| No call positions found | |
| Institution | Position Value |
|---|---|
| No put positions found | |
Institutions with PHVS as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
V venBio Partners LLC Institution | 65.62% $115.8M |
Foresite Capital Management IV, LLC Venture Capital | 65.29% $119.2M |
5 5AM Venture Management, LLC Institution | 7.29% $19.9M |
G GENERAL ATLANTIC LLC Institution | 6.02% $200.4M |
B Bain Capital Life Sciences Investors, LLC Institution | 5.27% $79.4M |
S Saturn V Capital Management LLC Hedge Fund•Sector | 4.85% $22.1M |
E EQT Fund Management S.a r.l. Institution | 4.59% $85.4M |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | 2.95% $60.3M |
N Novo A/S Institution | 2.87% $43.7M |
Octagon Capital Advisors LP Hedge Fund•Sector | 2.83% $18.0M |
Discover hedge funds investing in PHVS

| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Biotechnology Healthcare | $1.6B | 25.79% | |
Medical - Healthcare Plans Healthcare | $322.8M | 5.35% | |
Biotechnology Healthcare | $286.9M | 4.75% |
We use cookies for analytics. See our Privacy and Cookie Policy.